Global Antitussive Drugs Market Growth 2023-2029

February 2023 | 104 pages | ID: GA375ED598B9EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Antitussive Drugs Industry Forecast” looks at past sales and reviews total world Antitussive Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Antitussive Drugs sales for 2023 through 2029. With Antitussive Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antitussive Drugs industry.

This Insight Report provides a comprehensive analysis of the global Antitussive Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antitussive Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Antitussive Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antitussive Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antitussive Drugs.

The global Antitussive Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Antitussive Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Antitussive Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Antitussive Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Antitussive Drugs players cover Johnson & Johnson, Toray Industries, Pfizer, Novartis, Merck, Sanofi, AstraZeneca, Glenmark Pharmaceuticals and Alkem Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Antitussive Drugs market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Centrally Acting Antitussive Drugs
• Locally Acting Antitussive Drugs

Segmentation by application

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Johnson & Johnson
• Toray Industries
• Pfizer
• Novartis
• Merck
• Sanofi
• AstraZeneca
• Glenmark Pharmaceuticals
• Alkem Laboratories
• Zydus Cadila
• Cipla

Key Questions Addressed in this Report

What is the 10-year outlook for the global Antitussive Drugs market?

What factors are driving Antitussive Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Antitussive Drugs market opportunities vary by end market size?

How does Antitussive Drugs break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antitussive Drugs Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Antitussive Drugs by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Antitussive Drugs by Country/Region, 2018, 2022 & 2029
2.2 Antitussive Drugs Segment by Type
  2.2.1 Centrally Acting Antitussive Drugs
  2.2.2 Locally Acting Antitussive Drugs
2.3 Antitussive Drugs Sales by Type
  2.3.1 Global Antitussive Drugs Sales Market Share by Type (2018-2023)
  2.3.2 Global Antitussive Drugs Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Antitussive Drugs Sale Price by Type (2018-2023)
2.4 Antitussive Drugs Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Antitussive Drugs Sales by Application
  2.5.1 Global Antitussive Drugs Sale Market Share by Application (2018-2023)
  2.5.2 Global Antitussive Drugs Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Antitussive Drugs Sale Price by Application (2018-2023)

3 GLOBAL ANTITUSSIVE DRUGS BY COMPANY

3.1 Global Antitussive Drugs Breakdown Data by Company
  3.1.1 Global Antitussive Drugs Annual Sales by Company (2018-2023)
  3.1.2 Global Antitussive Drugs Sales Market Share by Company (2018-2023)
3.2 Global Antitussive Drugs Annual Revenue by Company (2018-2023)
  3.2.1 Global Antitussive Drugs Revenue by Company (2018-2023)
  3.2.2 Global Antitussive Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Antitussive Drugs Sale Price by Company
3.4 Key Manufacturers Antitussive Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Antitussive Drugs Product Location Distribution
  3.4.2 Players Antitussive Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR ANTITUSSIVE DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Antitussive Drugs Market Size by Geographic Region (2018-2023)
  4.1.1 Global Antitussive Drugs Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Antitussive Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Antitussive Drugs Market Size by Country/Region (2018-2023)
  4.2.1 Global Antitussive Drugs Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Antitussive Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Antitussive Drugs Sales Growth
4.4 APAC Antitussive Drugs Sales Growth
4.5 Europe Antitussive Drugs Sales Growth
4.6 Middle East & Africa Antitussive Drugs Sales Growth

5 AMERICAS

5.1 Americas Antitussive Drugs Sales by Country
  5.1.1 Americas Antitussive Drugs Sales by Country (2018-2023)
  5.1.2 Americas Antitussive Drugs Revenue by Country (2018-2023)
5.2 Americas Antitussive Drugs Sales by Type
5.3 Americas Antitussive Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Antitussive Drugs Sales by Region
  6.1.1 APAC Antitussive Drugs Sales by Region (2018-2023)
  6.1.2 APAC Antitussive Drugs Revenue by Region (2018-2023)
6.2 APAC Antitussive Drugs Sales by Type
6.3 APAC Antitussive Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Antitussive Drugs by Country
  7.1.1 Europe Antitussive Drugs Sales by Country (2018-2023)
  7.1.2 Europe Antitussive Drugs Revenue by Country (2018-2023)
7.2 Europe Antitussive Drugs Sales by Type
7.3 Europe Antitussive Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antitussive Drugs by Country
  8.1.1 Middle East & Africa Antitussive Drugs Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Antitussive Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Antitussive Drugs Sales by Type
8.3 Middle East & Africa Antitussive Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antitussive Drugs
10.3 Manufacturing Process Analysis of Antitussive Drugs
10.4 Industry Chain Structure of Antitussive Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Antitussive Drugs Distributors
11.3 Antitussive Drugs Customer

12 WORLD FORECAST REVIEW FOR ANTITUSSIVE DRUGS BY GEOGRAPHIC REGION

12.1 Global Antitussive Drugs Market Size Forecast by Region
  12.1.1 Global Antitussive Drugs Forecast by Region (2024-2029)
  12.1.2 Global Antitussive Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antitussive Drugs Forecast by Type
12.7 Global Antitussive Drugs Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Johnson & Johnson
  13.1.1 Johnson & Johnson Company Information
  13.1.2 Johnson & Johnson Antitussive Drugs Product Portfolios and Specifications
  13.1.3 Johnson & Johnson Antitussive Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Johnson & Johnson Main Business Overview
  13.1.5 Johnson & Johnson Latest Developments
13.2 Toray Industries
  13.2.1 Toray Industries Company Information
  13.2.2 Toray Industries Antitussive Drugs Product Portfolios and Specifications
  13.2.3 Toray Industries Antitussive Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Toray Industries Main Business Overview
  13.2.5 Toray Industries Latest Developments
13.3 Pfizer
  13.3.1 Pfizer Company Information
  13.3.2 Pfizer Antitussive Drugs Product Portfolios and Specifications
  13.3.3 Pfizer Antitussive Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Pfizer Main Business Overview
  13.3.5 Pfizer Latest Developments
13.4 Novartis
  13.4.1 Novartis Company Information
  13.4.2 Novartis Antitussive Drugs Product Portfolios and Specifications
  13.4.3 Novartis Antitussive Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Novartis Main Business Overview
  13.4.5 Novartis Latest Developments
13.5 Merck
  13.5.1 Merck Company Information
  13.5.2 Merck Antitussive Drugs Product Portfolios and Specifications
  13.5.3 Merck Antitussive Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Merck Main Business Overview
  13.5.5 Merck Latest Developments
13.6 Sanofi
  13.6.1 Sanofi Company Information
  13.6.2 Sanofi Antitussive Drugs Product Portfolios and Specifications
  13.6.3 Sanofi Antitussive Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Sanofi Main Business Overview
  13.6.5 Sanofi Latest Developments
13.7 AstraZeneca
  13.7.1 AstraZeneca Company Information
  13.7.2 AstraZeneca Antitussive Drugs Product Portfolios and Specifications
  13.7.3 AstraZeneca Antitussive Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 AstraZeneca Main Business Overview
  13.7.5 AstraZeneca Latest Developments
13.8 Glenmark Pharmaceuticals
  13.8.1 Glenmark Pharmaceuticals Company Information
  13.8.2 Glenmark Pharmaceuticals Antitussive Drugs Product Portfolios and Specifications
  13.8.3 Glenmark Pharmaceuticals Antitussive Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Glenmark Pharmaceuticals Main Business Overview
  13.8.5 Glenmark Pharmaceuticals Latest Developments
13.9 Alkem Laboratories
  13.9.1 Alkem Laboratories Company Information
  13.9.2 Alkem Laboratories Antitussive Drugs Product Portfolios and Specifications
  13.9.3 Alkem Laboratories Antitussive Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Alkem Laboratories Main Business Overview
  13.9.5 Alkem Laboratories Latest Developments
13.10 Zydus Cadila
  13.10.1 Zydus Cadila Company Information
  13.10.2 Zydus Cadila Antitussive Drugs Product Portfolios and Specifications
  13.10.3 Zydus Cadila Antitussive Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Zydus Cadila Main Business Overview
  13.10.5 Zydus Cadila Latest Developments
13.11 Cipla
  13.11.1 Cipla Company Information
  13.11.2 Cipla Antitussive Drugs Product Portfolios and Specifications
  13.11.3 Cipla Antitussive Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Cipla Main Business Overview
  13.11.5 Cipla Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Antitussive Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Antitussive Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Centrally Acting Antitussive Drugs
Table 4. Major Players of Locally Acting Antitussive Drugs
Table 5. Global Antitussive Drugs Sales by Type (2018-2023) & (K Units)
Table 6. Global Antitussive Drugs Sales Market Share by Type (2018-2023)
Table 7. Global Antitussive Drugs Revenue by Type (2018-2023) & ($ million)
Table 8. Global Antitussive Drugs Revenue Market Share by Type (2018-2023)
Table 9. Global Antitussive Drugs Sale Price by Type (2018-2023) & (USD/Units)
Table 10. Global Antitussive Drugs Sales by Application (2018-2023) & (K Units)
Table 11. Global Antitussive Drugs Sales Market Share by Application (2018-2023)
Table 12. Global Antitussive Drugs Revenue by Application (2018-2023)
Table 13. Global Antitussive Drugs Revenue Market Share by Application (2018-2023)
Table 14. Global Antitussive Drugs Sale Price by Application (2018-2023) & (USD/Units)
Table 15. Global Antitussive Drugs Sales by Company (2018-2023) & (K Units)
Table 16. Global Antitussive Drugs Sales Market Share by Company (2018-2023)
Table 17. Global Antitussive Drugs Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Antitussive Drugs Revenue Market Share by Company (2018-2023)
Table 19. Global Antitussive Drugs Sale Price by Company (2018-2023) & (USD/Units)
Table 20. Key Manufacturers Antitussive Drugs Producing Area Distribution and Sales Area
Table 21. Players Antitussive Drugs Products Offered
Table 22. Antitussive Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Antitussive Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Antitussive Drugs Sales Market Share Geographic Region (2018-2023)
Table 27. Global Antitussive Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Antitussive Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Antitussive Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Antitussive Drugs Sales Market Share by Country/Region (2018-2023)
Table 31. Global Antitussive Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Antitussive Drugs Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Antitussive Drugs Sales by Country (2018-2023) & (K Units)
Table 34. Americas Antitussive Drugs Sales Market Share by Country (2018-2023)
Table 35. Americas Antitussive Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Antitussive Drugs Revenue Market Share by Country (2018-2023)
Table 37. Americas Antitussive Drugs Sales by Type (2018-2023) & (K Units)
Table 38. Americas Antitussive Drugs Sales by Application (2018-2023) & (K Units)
Table 39. APAC Antitussive Drugs Sales by Region (2018-2023) & (K Units)
Table 40. APAC Antitussive Drugs Sales Market Share by Region (2018-2023)
Table 41. APAC Antitussive Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Antitussive Drugs Revenue Market Share by Region (2018-2023)
Table 43. APAC Antitussive Drugs Sales by Type (2018-2023) & (K Units)
Table 44. APAC Antitussive Drugs Sales by Application (2018-2023) & (K Units)
Table 45. Europe Antitussive Drugs Sales by Country (2018-2023) & (K Units)
Table 46. Europe Antitussive Drugs Sales Market Share by Country (2018-2023)
Table 47. Europe Antitussive Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Antitussive Drugs Revenue Market Share by Country (2018-2023)
Table 49. Europe Antitussive Drugs Sales by Type (2018-2023) & (K Units)
Table 50. Europe Antitussive Drugs Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Antitussive Drugs Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Antitussive Drugs Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Antitussive Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Antitussive Drugs Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Antitussive Drugs Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Antitussive Drugs Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Antitussive Drugs
Table 58. Key Market Challenges & Risks of Antitussive Drugs
Table 59. Key Industry Trends of Antitussive Drugs
Table 60. Antitussive Drugs Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Antitussive Drugs Distributors List
Table 63. Antitussive Drugs Customer List
Table 64. Global Antitussive Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Antitussive Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Antitussive Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Antitussive Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Antitussive Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Antitussive Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Antitussive Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Antitussive Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Antitussive Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Antitussive Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Antitussive Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Antitussive Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Antitussive Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Antitussive Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Johnson & Johnson Basic Information, Antitussive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Johnson & Johnson Antitussive Drugs Product Portfolios and Specifications
Table 80. Johnson & Johnson Antitussive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2018-2023)
Table 81. Johnson & Johnson Main Business
Table 82. Johnson & Johnson Latest Developments
Table 83. Toray Industries Basic Information, Antitussive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Toray Industries Antitussive Drugs Product Portfolios and Specifications
Table 85. Toray Industries Antitussive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2018-2023)
Table 86. Toray Industries Main Business
Table 87. Toray Industries Latest Developments
Table 88. Pfizer Basic Information, Antitussive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer Antitussive Drugs Product Portfolios and Specifications
Table 90. Pfizer Antitussive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2018-2023)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Novartis Basic Information, Antitussive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Novartis Antitussive Drugs Product Portfolios and Specifications
Table 95. Novartis Antitussive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2018-2023)
Table 96. Novartis Main Business
Table 97. Novartis Latest Developments
Table 98. Merck Basic Information, Antitussive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Antitussive Drugs Product Portfolios and Specifications
Table 100. Merck Antitussive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2018-2023)
Table 101. Merck Main Business
Table 102. Merck Latest Developments
Table 103. Sanofi Basic Information, Antitussive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Sanofi Antitussive Drugs Product Portfolios and Specifications
Table 105. Sanofi Antitussive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2018-2023)
Table 106. Sanofi Main Business
Table 107. Sanofi Latest Developments
Table 108. AstraZeneca Basic Information, Antitussive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. AstraZeneca Antitussive Drugs Product Portfolios and Specifications
Table 110. AstraZeneca Antitussive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2018-2023)
Table 111. AstraZeneca Main Business
Table 112. AstraZeneca Latest Developments
Table 113. Glenmark Pharmaceuticals Basic Information, Antitussive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Glenmark Pharmaceuticals Antitussive Drugs Product Portfolios and Specifications
Table 115. Glenmark Pharmaceuticals Antitussive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2018-2023)
Table 116. Glenmark Pharmaceuticals Main Business
Table 117. Glenmark Pharmaceuticals Latest Developments
Table 118. Alkem Laboratories Basic Information, Antitussive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Alkem Laboratories Antitussive Drugs Product Portfolios and Specifications
Table 120. Alkem Laboratories Antitussive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2018-2023)
Table 121. Alkem Laboratories Main Business
Table 122. Alkem Laboratories Latest Developments
Table 123. Zydus Cadila Basic Information, Antitussive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Zydus Cadila Antitussive Drugs Product Portfolios and Specifications
Table 125. Zydus Cadila Antitussive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2018-2023)
Table 126. Zydus Cadila Main Business
Table 127. Zydus Cadila Latest Developments
Table 128. Cipla Basic Information, Antitussive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Cipla Antitussive Drugs Product Portfolios and Specifications
Table 130. Cipla Antitussive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2018-2023)
Table 131. Cipla Main Business
Table 132. Cipla Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Antitussive Drugs
Figure 2. Antitussive Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antitussive Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Antitussive Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Antitussive Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Centrally Acting Antitussive Drugs
Figure 10. Product Picture of Locally Acting Antitussive Drugs
Figure 11. Global Antitussive Drugs Sales Market Share by Type in 2022
Figure 12. Global Antitussive Drugs Revenue Market Share by Type (2018-2023)
Figure 13. Antitussive Drugs Consumed in Hospital Pharmacies
Figure 14. Global Antitussive Drugs Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 15. Antitussive Drugs Consumed in Retail Pharmacies
Figure 16. Global Antitussive Drugs Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 17. Antitussive Drugs Consumed in Online Pharmacies
Figure 18. Global Antitussive Drugs Market: Online Pharmacies (2018-2023) & (K Units)
Figure 19. Global Antitussive Drugs Sales Market Share by Application (2022)
Figure 20. Global Antitussive Drugs Revenue Market Share by Application in 2022
Figure 21. Antitussive Drugs Sales Market by Company in 2022 (K Units)
Figure 22. Global Antitussive Drugs Sales Market Share by Company in 2022
Figure 23. Antitussive Drugs Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Antitussive Drugs Revenue Market Share by Company in 2022
Figure 25. Global Antitussive Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Antitussive Drugs Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Antitussive Drugs Sales 2018-2023 (K Units)
Figure 28. Americas Antitussive Drugs Revenue 2018-2023 ($ Millions)
Figure 29. APAC Antitussive Drugs Sales 2018-2023 (K Units)
Figure 30. APAC Antitussive Drugs Revenue 2018-2023 ($ Millions)
Figure 31. Europe Antitussive Drugs Sales 2018-2023 (K Units)
Figure 32. Europe Antitussive Drugs Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Antitussive Drugs Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Antitussive Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Americas Antitussive Drugs Sales Market Share by Country in 2022
Figure 36. Americas Antitussive Drugs Revenue Market Share by Country in 2022
Figure 37. Americas Antitussive Drugs Sales Market Share by Type (2018-2023)
Figure 38. Americas Antitussive Drugs Sales Market Share by Application (2018-2023)
Figure 39. United States Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Antitussive Drugs Sales Market Share by Region in 2022
Figure 44. APAC Antitussive Drugs Revenue Market Share by Regions in 2022
Figure 45. APAC Antitussive Drugs Sales Market Share by Type (2018-2023)
Figure 46. APAC Antitussive Drugs Sales Market Share by Application (2018-2023)
Figure 47. China Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Antitussive Drugs Sales Market Share by Country in 2022
Figure 55. Europe Antitussive Drugs Revenue Market Share by Country in 2022
Figure 56. Europe Antitussive Drugs Sales Market Share by Type (2018-2023)
Figure 57. Europe Antitussive Drugs Sales Market Share by Application (2018-2023)
Figure 58. Germany Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Antitussive Drugs Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Antitussive Drugs Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Antitussive Drugs Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Antitussive Drugs Sales Market Share by Application (2018-2023)
Figure 67. Egypt Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Antitussive Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Antitussive Drugs in 2022
Figure 73. Manufacturing Process Analysis of Antitussive Drugs
Figure 74. Industry Chain Structure of Antitussive Drugs
Figure 75. Channels of Distribution
Figure 76. Global Antitussive Drugs Sales Market Forecast by Region (2024-2029)
Figure 77. Global Antitussive Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Antitussive Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Antitussive Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Antitussive Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Antitussive Drugs Revenue Market Share Forecast by Application (2024-2029)